Skip to main content
SpringerLink
Log in

Early use of WES cost effective in children

  • Unknown
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tan TY, et al. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. JAMA Pediatrics : 31 Jul 2017. Available from: URL: http://dx.doi.org/10.1001/jamapediatrics.2017.1755.

  2. Lemke JR. High-Throughput Sequencing as First-Tier Diagnostics in Congenital and Early-Onset Disorders. JAMA Pediatrics : 31 Jul 2017. Available from: URL: http://dx.doi.org/10.1001/jamapediatrics.2017.1970.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Early use of WES cost effective in children. PharmacoEcon Outcomes News 784, 14 (2017). https://doi.org/10.1007/s40274-017-4225-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4225-z

Search

Navigation